Actively Recruiting
Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
Led by Candiolo Cancer Institute - IRCCS · Updated on 2025-06-24
150
Participants Needed
1
Research Sites
135 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
CONDITIONS
Official Title
Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 55 years
- Underwent surgery for early stage breast cancer
- Taking endocrine therapy for at least 3 months
- Willing to provide informed consent and complete study questionnaires
You will not qualify if you...
- Withdrawal of informed consent at any time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Candiolo Cancer Center
Torino, TO, Italy, 10060
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here